EZH2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M, Nazdari N, Gholamiyan G, Paskeh MDA, Jafari AM, Nemati F, Khodaei E, Abyari G, Behdadfar N, Raei B, Raesi R, Nabavi N, Hu P, Rashidi M, Taheriazam A, Entezari M.
Hashemi M, et al. Among authors: jafari am.
Pathol Res Pract. 2024 Jan;253:154988. doi: 10.1016/j.prp.2023.154988. Epub 2023 Nov 29.
Pathol Res Pract. 2024.
PMID: 38118215
Review.